Alto NeuroscienceANRO

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$382.3M

Market Cap • 03/05/2024

2019

(há 5 anos)
Fundação

2024

IPO

NYSE

Listagem
Flag of US

Los Altos

Sede • California

Valuation

Valuation Indicators

Retorno Histórico

ANROSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-8%

1 dia

30/04/2024

0%

1 semana

26/04/2024

0%

1 mês

03/04/2024

10 anos

Histórico